Caroline M. M. van Geelen

Statistics

Publications

Citations

458

H-Index

Active since

2003

Affiliations

AIMM Therapeutics (Netherlands)(Current)

Amsterdam UMC Location University of Amsterdam

University Medical Center Groningen

Caroline M. M. van Geelen is an author at AIMM Therapeutics (Netherlands) specializing in life sciences, apoptosis, and monoclonal antibody technology.

Publications per year

2003–2010

Publications

Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Mark J. Kwakkenbos, Sean A. Diehl, Etsuko Yasuda et al. · Nature Medicine · 2009 · 302 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated “Human Immune System” Mice

Pablo D. Becker, Nicolas Legrand, Caroline M. M. van Geelen et al. · PLoS ONE · 2010 · 70 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines

Caroline M. M. van Geelen, Elisabeth G.E. de Vries, T K P Le et al. · British Journal of Cancer · 2003 · 62 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Modulation of death receptor pathways in oncology.

Elisabeth G.E. de Vries, Tineke Timmer, N. H. Mulder et al. · PubMed · 2003 · 24 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4